Delivery Order SPE2DB20D2104-SPE2DB23FU72X
Award Date 8/4/23
Potential Completion Date 8/7/23
Potential Value $215
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $17,760 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to provide 100 tablets of 100 milligram bupropion hydrochloride. The single day contract has a period of performance from September 21 through September 22, 2023, with all work taking place in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether this delivery...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $15,300 delivery order by the Defense Logistics Agency to supply 90-count bottles of 300mg Bupropion HCL extended-release tablets. Performance will take place in Conshohocken, Pennsylvania under a firm fixed-price contract spanning September 19-20, 2023. The Defense Logistics Agency routinely issues such requirements on its Prime Vendor-Pharmaceutical program to support the medical readiness of...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $47,500 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to provide 90 boxes of 150mg Bupropion HCL XL tablets. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 29, 2023 through August 30, 2023. No subcontractors or set aside designations were identified. This delivery order...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $411 delivery order by the Defense Logistics Agency to supply 450mg bupropion HCL extended-release tablets. The firm fixed-price order is for 30 tablets to be delivered to a facility in Conshohocken, Pennsylvania between August 10-11, 2023. No set-aside designation or subcontractors were identified. The Defense Logistics Agency routinely procures pharmaceuticals to support the medical readiness of...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a delivery order valued at $20,340 by the Defense Logistics Agency to provide 60 count bottles of 200mg bupropion hydrochloride sustained release tablets. The contract has a period of performance from August 25, 2023 through August 28, 2023. Pricing is firm fixed. The Defense Logistics Agency will utilize this order under their Prime Vendor program to support pharmaceutical needs at military...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The $14,133.14 award is for the delivery of bupropion hydrochloride extended-release 150 mg tablets to support DLA Troop Support Medical programs and facilities. Amerisourcebergen Drug Corp has a track record of providing pharmaceuticals and medical supplies to DLA under various...
- The Defense Logistics Agency awarded a $1,011.10 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 450 mg bupropion hydrochloride extended-release tablets. The prime contractor, Amerisourcebergen Drug Corporation, will deliver 30 tablets from its Conshohocken, Pennsylvania facility by August 17, 2023 to support the Defense Logistics Agency's pharmaceutical supply needs. No major subcontractors or set aside designations were indicated. The delivery order...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 500 tablets of bupropion hydrochloride extended-release 150 mg. The delivery order is a firm fixed price contract with a potential value of $4,057.32 and a completion date of January 5, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is a prime contractor that provides a range of...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at three hundred eleven dollars and eighty-three cents to Amerisourcebergen Drug Corp Corporate Office Division for five hundred tablets of 150mg bupropion hydrochloride extended release. As a prime contractor for the Defense Logistics Agency, Amerisourcebergen Drug will deliver the generic antidepressant to a facility in Conshohocken, Pennsylvania under a single day contract starting and ending...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at one hundred seventy-two dollars and forty-one cents to Amerisourcebergen Drug Corporation for the provision of five hundred tablets of bupropion hydrochloride extended-release 300 milligrams. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is from August 31, 2023 through September 1, 2023. As a major provider of pharmaceuticals and...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FU72XDelivery Order
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a delivery order valued at two hundred fifteen dollars and forty-six cents ($215.46) by the Defense Logistics Agency on behalf of the Department of Defense. The firm fixed price order is for the delivery of thirty (30) 450mg tablets of bupropion hydrochloride extended release to a facility located in Conshohocken, Pennsylvania. Performance will take place between August 4th and August 7th, 2023. No subcontractors or set aside designations were identified. The award is likely placed against the DLA's Pharmaceutical Prime Vendor contract to support the medical readiness of DOD personnel.
Generated 12/19/23, 11:11 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $215 | 8/4/23 |